Xeris Biopharma Holdings, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Xeris Biopharma Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2021 to Q3 2024.
  • Xeris Biopharma Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 149M shares, a 7.93% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 149M +11M +7.93% Oct 31, 2024 10-Q 2024-11-08
Q2 2024 149M +10.9M +7.92% Jul 31, 2024 10-Q 2024-08-08
Q1 2024 148M +10.9M +7.97% Apr 30, 2024 10-Q 2024-05-09
Q3 2023 138M +2.14M +1.57% Oct 31, 2023 10-Q 2023-11-09
Q2 2023 138M +2.11M +1.55% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 137M +1.78M +1.31% May 1, 2023 10-Q 2023-05-09
Q3 2022 136M +11.3M +9.04% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 136M Jul 31, 2022 10-Q 2022-08-10
Q1 2022 136M Apr 30, 2022 10-Q 2022-05-11
Q3 2021 125M Oct 31, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.